Revenio Group Corporation, Stock Exchange Release, December 29, 2015 at 13.00
REVENIO GROUP'S FINANCIAL REPORTING IN 2016
During 2016, Revenio Group Corporation will publish the following financial reports:
- Financial Statements bulletin in regard to 2015 on Monday, February 15, 2016
- Interim Report 1-3/2016 on Monday, April 25, 2016
- Interim Report 1-6/2016 on Monday, August 8, 2016
- Interim Report 1-9/2016 on Monday, October 31, 2016
Due to an amendment in the Securities Market Act, which came into force on 26 November 2015, Revenio will publish the descriptive sections of its interim reports for 1-3/2016 and 1-9/2016 in a more concise form than before. The table sections will be reported in accordance with previous practices.
The Annual General Meeting is planned to be held on Tuesday, March 15, 2016.
Annual Report for 2015 will be published during week 8 in 2016.
Revenio Group Oyj
Olli-Pekka Salovaara
CEO
For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi
DISTRIBUTION:
NASDAQ Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi
The Revenio Group in brief
Revenio is a Finnish health tech group whose core business is in tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy, Revenio Research Oy and Oscare Medical Oy, which specializes in osteoporosis screening and monitoring. In addition, Revenio has identified new growth opportunities relating to health tech in which common denominators are screening, follow-up and the global need to make cost savings in health care via preventive measures. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers.
In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating profit (EBIT) from continuing operations standing at 27.5%. The Revenio Group Corporation is listed on NASDAQ OMX Helsinki.